FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Christer von Bahr

Research Profile

Physiology

Drug Interactions

Geographic Areas

Sweden

Chemicals & Drugs

Procedures

Concepts & Ideas

Co-author Network

Publications

TOP 3
Lars ´Gustafsson; Björn Wettermark; Brian Godman; Eva Andersén-Karlsson; Ulf Bergman; Jan Hasselström; Lars-Olof Hensjö; Paul Hjemdahl; Ingrid Jägre; Margaretha Julander; Bo Ringertz; Daniel Schmidt; Susan Sjöberg; Folke Sjöqvist; Carl-Olav Stiller; Elisabeth Törnqvist; Rolf Tryselius; Sigurd Vitols; Christer von Bahr
The 'wise list'- a comprehensive concept to select, communicate and achieve adherence to recommendations of essential drugs in ambulatory care in Stockholm.
Buster Mannheimer; Johanna Ulfvarson; Sara Eklöf; Monica Bergqvist; Christer von Bahr
A clinical evaluation of the Janus Web Application, a software screening tool for drug-drug interactions.
Buster Mannheimer; Christer von Bahr; Hans Pettersson; Erik Eliasson
Impact of multiple inhibitors or substrates of cytochrome P450 2D6 on plasma risperidone levels in patients on polypharmacy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Christer von Bahr (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Lars ´Gustafsson; Björn Wettermark; Brian Godman; Eva Andersén-Karlsson; Ulf Bergman; Jan Hasselström; Lars-Olof Hensjö; Paul Hjemdahl; Ingrid Jägre; Margaretha Julander; Bo Ringertz; Daniel Schmidt; Susan Sjöberg; Folke Sjöqvist; Carl-Olav Stiller; Elisabeth Törnqvist; Rolf Tryselius; Sigurd Vitols; Christer von Bahr
The 'wise list'- a comprehensive concept to select, communicate and achieve adherence to recommendations of essential drugs in ambulatory care in Stockholm.
Basic & clinical pharmacology & toxicology 2011;108(4):224-33.
2008: Buster Mannheimer; Johanna Ulfvarson; Sara Eklöf; Monica Bergqvist; Christer von Bahr
A clinical evaluation of the Janus Web Application, a software screening tool for drug-drug interactions.
European journal of clinical pharmacology 2008;64(12):1209-14.
2008: Buster Mannheimer; Christer von Bahr; Hans Pettersson; Erik Eliasson
Impact of multiple inhibitors or substrates of cytochrome P450 2D6 on plasma risperidone levels in patients on polypharmacy.
Therapeutic drug monitoring 2008;30(5):565-9.
2008: Monica Bergqvist; Johanna Ulfvarson; Eva Andersen Karlsson; Christer von Bahr
A nurse-led intervention for identification of drug-related problems.
European journal of clinical pharmacology 2008;64(5):451-6.
2007: Johanna Ulfvarson; Carola Bardage; Regina Wredling; Christer von Bahr; Johanna Adami
Adherence to drug treatment in association with how the patient perceives care and information on drugs.
Journal of clinical nursing 2007;16(1):141-8.
2006: Buster Mannheimer; Johanna Ulfvarson; Sara Eklöf; Monica Bergqvist; Eva Andersén-Karlsson; Hans Pettersson; Christer von Bahr
Drug-related problems and pharmacotherapeutic advisory intervention at a medicine clinic.
European journal of clinical pharmacology 2006;62(12):1075-81.
2005: Johanna Ulfvarson; Johanna Adami; Carola Bardage; Christer von Bahr; Regina Wredling
Drug use and perceived health in recently hospitalized older people.
British journal of community nursing 2005;10(10):469-74.
2005: Carina Ursing; Christer von Bahr; Kerstin Brismar; Sven Röjdmark
Influence of cigarette smoking on melatonin levels in man.
European journal of clinical pharmacology 2005;61(3):197-201.
2004: Marianne Jägestedt; Christer von Bahr
[Combination of serotonergic agents resulted in severe adverse effects].
Läkartidningen 2004;101(18):1618-9.
2003: Johanna Ulfvarson; Johanna Adami; Regina Wredling; Bengt Kjellman; Marie Reilly; Christer von Bahr
Controlled withdrawal of selective serotonin reuptake inhibitor drugs in elderly patients in nursing homes with no indication of depression.
European journal of clinical pharmacology 2003;59(10):735-40.
2003: Johanna Ulfvarson; Johanna Adami; Bengt Ullman; Regina Wredling; Marie Reilly; Christer von Bahr
Randomized controlled intervention in cardiovascular drug treatment in nursing homes.
Pharmacoepidemiology and drug safety 2003;12(7):589-93.
2002: Sven Röjdmark; Christer von Bahr
[Metabolic interaction between psychopharmaceuticals. Probable cause of exacerbation of hypothyroidism according to a case report].
Läkartidningen 2002;99(25):2854-6.
2002: Carina Ursing; Sebastian Härtter; Christer von Bahr; Gunnel Tybring; Leif Bertilsson; Sven Röjdmark
Does hepatic metabolism of melatonin affect the endogenous serum melatonin level in man?
Journal of endocrinological investigation 2002;25(5):459-62.
2001: C Sarlöv; Eva Andersén-Karlsson; Christer von Bahr
[Adverse effects of drugs in patients with heart disease lead to hospital care].
Läkartidningen 2001;98(47):5349-53.
2001: Sebastian Härtter; Carina Ursing; S Morita; Gunnel Tybring; Christer von Bahr; Magnus Christensen; Sven Röjdmark; Leif Bertilsson
Orally given melatonin may serve as a probe drug for cytochrome P450 1A2 activity in vivo: a pilot study.
Clinical pharmacology and therapeutics 2001;70(1):10-6.
2001: G Facciolá; Mats Hidestrand; Christer von Bahr; Gunnel Tybring
Cytochrome P450 isoforms involved in melatonin metabolism in human liver microsomes.
European journal of clinical pharmacology 2001;56(12):881-8.
2000: Christer von Bahr; Carina Ursing; N Yasui; Gunnel Tybring; Leif Bertilsson; Sven Röjdmark
Fluvoxamine but not citalopram increases serum melatonin in healthy subjects-- an indication that cytochrome P450 CYP1A2 and CYP2C19 hydroxylate melatonin.
European journal of clinical pharmacology 2000;56(2):123-7.
1998: Christer von Bahr; E Steiner; Y Koike; J Gabrielsson
Time course of enzyme induction in humans: effect of pentobarbital on nortriptyline metabolism.
Clinical pharmacology and therapeutics 1998;64(1):18-26.